955857731	955857731	CD	B-NP	O
|	|	NN	I-NP	O
RCHO	RCHO	NN	I-NP	O
|	|	NN	I-NP	O
31277434	31277434	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5516069	5516069	CD	B-NP	O
|	|	CC	I-NP	O
10/21/2004	10/21/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
r/o	r/o	NN	I-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
SOB	SOB	NN	B-NP	B-protein
multifactorial	multifactorial	JJ	I-NP	O
deconditioning	deconditioning	NN	I-NP	O
,	,	,	O	O
pulmon	pulmon	NN	B-NP	O
disease	disease	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/21/2004	10/21/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/12/2004	5/12/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
REDRICK	REDRICK	NNP	B-NP	O
,	,	,	O	O
CRAIG	CRAIG	NNP	B-NP	O
MATTHEW	MATTHEW	NNP	I-NP	O
595-27-53-0	595-27-53-0	CD	I-NP	O
Arkansas	Arkansas	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
8/29/04	8/29/04	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GIGGER	GIGGER	NNP	B-NP	O
,	,	,	O	O
JERALD	JERALD	NNP	B-NP	O
DARRYL	DARRYL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
AMITRIPTYLINE	AMITRIPTYLINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/4/04	8/4/04	CD	B-NP	O
by	by	IN	B-PP	O
ORMS	ORMS	NN	B-NP	B-protein
,	,	,	O	O
EDDIE	EDDIE	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
FUROSEMIDE	FUROSEMIDE	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
59678227	59678227	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Sulfa	Sulfa	NNP	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	JJ	B-NP	O
tol	tol	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
GLYBURIDE	GLYBURIDE	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/4/04	8/4/04	CD	B-NP	O
by	by	IN	B-PP	O
OAKES	OAKES	NN	B-NP	B-protein
,	,	,	O	O
ROOSEVELT	ROOSEVELT	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
GLYBURIDE	GLYBURIDE	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	O
98675198	98675198	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Sulfa	Sulfa	NNP	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
takes	take	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
NOVOLIN	NOVOLIN	NN	I-NP	O
INNOLET	INNOLET	NN	I-NP	O
70/30	70/30	CD	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
70/30	70/30	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
HUMAN	HUMAN	NN	I-NP	B-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
100	100	CD	I-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
SC	SC	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
8	8	CD	B-NP	O
NORVASC	NORVASC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

LIPITOR	LIPITOR	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/4/04	8/4/04	CD	B-NP	O
by	by	IN	B-PP	O
GASTINEAU	GASTINEAU	NN	B-NP	O
,	,	,	O	O
RAMIRO	RAMIRO	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
CLOTRIMAZOLE	CLOTRIMAZOLE	NN	B-NP	O
1	1	CD	I-NP	O
%	%	NN	I-NP	O
CREAM	CREAM	NN	I-NP	O
TP	TP	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
02025691	02025691	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
CLOTRIMAZOLE	CLOTRIMAZOLE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/4/04	8/4/04	CD	B-NP	O
by	by	IN	B-PP	O
ARDELEAN	ARDELEAN	NN	B-NP	O
,	,	,	O	O
TRACY	TRACY	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LIPITOR	LIPITOR	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
39942376	39942376	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	B-protein
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
myalgia	myalgia	NN	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	JJ	B-NP	O
tol	tol	NN	I-NP	O
lipitor	lipitor	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Giangrosso	Giangrosso	NNP	I-NP	O
SH	SH	NNP	I-NP	O
call	call	NN	I-NP	O
to	to	TO	B-VP	O
schedule	schedule	VB	I-VP	O
1wk	1wk	NN	B-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
ACE	ACE	NNP	B-NP	O
Inhibitor	Inhibitor	NNP	I-NP	O
,	,	,	O	O
METFORMIN	METFORMIN	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
,	,	,	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
,	,	,	O	O
DRUG	DRUG	NNP	B-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
SOB/Chest	SOB/Chest	NNP	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
r/o	r/o	NNP	I-NP	O
MI	MI	NNP	I-NP	O
,	,	,	O	O
SOB	SOB	NNP	B-NP	O
multifactorial	multifactorial	JJ	I-NP	O
deconditioning	deconditioning	NN	I-NP	O
,	,	,	O	O
pulmon	pulmon	NN	B-NP	O
disease	disease	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	O
,	,	,	O	O
uncontrolled	uncontrolled	JJ	B-NP	O
DM	DM	NNP	I-NP	O
,	,	,	O	O
Sleep	Sleep	NNP	B-NP	O
Apnea	Apnea	NNP	I-NP	O
,	,	,	O	O
Asthma	Asthma	NNP	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
58	58	CD	B-NP	O
yo	yo	NN	I-NP	O
woman	woman	NN	I-NP	O
multiple	multiple	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
-LRB-	-LRB-	VBP	B-VP	O
uncontrolled	uncontrolled	JJ	B-NP	O
DM2	DM2	NN	I-NP	O
10.3	10.3	CD	I-NP	O
HgbAIC	HgbAIC	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
lipids	lipid	VBZ	B-VP	O
-RRB-	-RRB-	NNP	B-NP	O
,	,	,	O	O
Asthma	Asthma	NNP	B-NP	O
,	,	,	O	O
Sleep	Sleep	NNP	B-NP	O
Apnea	Apnea	NNP	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
worsening	worsen	VBG	B-VP	O
DOE	DOE	NNP	B-NP	O
.	.	.	O	O

Pt	Pt	NNP	B-NP	O
c/o	c/o	NN	I-NP	O
DOE	DOE	NNP	I-NP	O
only	only	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
walking	walk	VBG	B-VP	O
up	up	RP	B-PRT	O
an	an	DT	B-NP	O
incline	incline	NN	I-NP	O
.	.	.	O	O

pt	pt	NN	B-NP	O
had	have	VBD	B-VP	O
one	one	CD	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
diaphoresis	diaphoresis	NN	B-NP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
SOB	SOB	NN	I-NP	B-protein
but	but	CC	O	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
cp	cp	NN	I-NP	B-DNA
,	,	,	O	O
shoulder	shoulder	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
backpain	backpain	NN	B-NP	O
,	,	,	O	O
jaw/neck	jaw/neck	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

pt	pt	NN	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
n/v/d	n/v/d	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
went	go	VBD	B-VP	O
to	to	TO	B-PP	O
PCP	PCP	NN	B-NP	B-DNA
and	and	CC	O	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
multiple	multiple	JJ	B-NP	O
risk	risk	NN	I-NP	O
factors	factor	NNS	I-NP	O
was	be	VBD	B-VP	O
told	tell	VBN	I-VP	O
to	to	TO	I-VP	O
come	come	VB	I-VP	O
to	to	TO	B-VP	O
ED	ED	VBN	I-VP	O
for	for	IN	B-PP	O
r/o	r/o	NN	B-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

pt	pt	NN	B-NP	O
denies	deny	VBZ	B-VP	O
SOB	SOB	NN	B-NP	B-protein
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
or	or	CC	O	O
even	even	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
walking	walk	VBG	B-VP	O
on	on	IN	B-PP	O
``	``	``	O	O
flat	flat	JJ	B-NP	O
surface	surface	NN	I-NP	O
''	''	''	I-NP	O
pt	pt	NN	I-NP	O
says	say	VBZ	B-VP	O
been	be	VBN	I-VP	O
over	over	IN	B-PP	O
all	all	DT	B-NP	O
fatigue	fatigue	NN	I-NP	O
last	last	JJ	B-NP	O
week	week	NN	I-NP	O
also	also	RB	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
recovering	recover	VBG	I-VP	O
from	from	IN	B-PP	O
recent	recent	JJ	B-NP	O
renal	renal	JJ	I-NP	O
stone	stone	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
admit	admit	NN	I-NP	O
for	for	IN	B-PP	O
r/o	r/o	NN	B-NP	O
MI	MI	NN	I-NP	O
In	In	IN	B-PP	O
ED	ED	JJ	B-NP	B-protein
pt	pt	NN	I-NP	I-protein
BP	BP	NN	I-NP	I-protein
elevated	elevate	VBD	B-VP	O
150-160	150-160	CD	B-NP	O
's	's	POS	B-NP	O
/	/	SYM	I-NP	O
80-90	80-90	CD	I-NP	O
given	give	VBN	B-VP	O
IV	IV	CD	B-NP	O
lopressor	lopressor	NN	I-NP	O
and	and	CC	I-NP	O
nitro	nitro	NN	I-NP	O
paste	paste	NN	I-NP	O
pt	pt	NN	I-NP	O
BP	BP	NN	I-NP	O
stable	stable	JJ	I-NP	O
A/P	A/P	NN	I-NP	O
DOE	DOE	NN	I-NP	O
unlikely	unlikely	JJ	B-ADJP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
cardiac	cardiac	JJ	B-NP	O
problem	problem	NN	I-NP	O
,	,	,	O	O
symptoms	symptom	NNS	B-NP	O
more	more	RBR	B-NP	O
c/w	c/w	JJ	I-NP	O
deconditioning	deconditioning	NN	I-NP	O
in	in	IN	B-PP	O
obese	obese	NN	B-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
women	woman	NNS	I-NP	O
with	with	IN	B-PP	O
underlying	underlie	VBG	B-VP	O
pulmon	pulmon	NN	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
-	-	HYPH	I-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
enz	enz	NN	I-NP	I-protein
neg	neg	NN	I-NP	I-protein
x3	x3	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
ASA	ASA	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
BB	BB	NN	I-NP	O
secondary	secondary	JJ	I-NP	O
Asthma	Asthma	NN	I-NP	O
Will	Will	NNP	I-NP	O
need	need	VBP	B-VP	O
cardiac	cardiac	JJ	B-NP	O
mibi	mibi	NNS	I-NP	O
with	with	IN	B-PP	O
adenosine	adenosine	NN	B-NP	O
as	as	IN	B-PP	O
out	out	IN	B-PP	O
patient	patient	NN	B-NP	O
hx	hx	NN	I-NP	O
diasystolic	diasystolic	JJ	I-NP	O
dysfunc	dysfunc	NN	I-NP	O
with	with	IN	B-PP	O
nl	nl	NN	B-NP	B-protein
EF	EF	NN	I-NP	I-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

Serial	Serial	JJ	B-NP	O
EKGs	EKG	NNS	I-NP	O
unchanged	unchanged	JJ	B-ADJP	O
with	with	IN	B-PP	O
baseline	baseline	NN	B-NP	B-protein
abnl	abnl	NN	I-NP	I-protein
poor	poor	JJ	I-NP	I-protein
RWprogression	RWprogression	NN	I-NP	I-protein
BP	BP	NN	I-NP	I-protein
initially	initially	RB	B-VP	O
mildly	mildly	RB	I-VP	O
elevated	elevate	VBD	I-VP	O
stable	stable	JJ	B-ADJP	O
this	this	DT	B-NP	O
am	am	NN	I-NP	O
can	can	MD	B-VP	O
rea	rea	VB	I-VP	O
ddress	ddress	NN	B-NP	O
meds	med	NNS	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpt	outpt	JJ	I-NP	O
Endo	Endo	NNP	I-NP	O
-	-	HYPH	I-NP	O
DM	DM	NN	I-NP	O
cont	cont	NN	I-NP	O
home	home	NN	I-NP	O
meds	med	NNS	I-NP	O
SSI	SSI	NN	I-NP	O
Pulmon	Pulmon	NN	I-NP	O
-	-	HYPH	B-NP	O
hx	hx	NN	I-NP	O
sleep	sleep	NN	I-NP	O
apnea/Asthma	apnea/Asthma	NN	I-NP	O
on	on	IN	B-PP	O
cpap	cpap	NN	B-NP	O
/	/	SYM	I-NP	O
6lNC	6lNC	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
hosp	hosp	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O

no	no	DT	B-NP	O
baseline	baseline	NN	I-NP	O
O2	O2	NN	I-NP	O
needed	need	VBN	B-VP	O
Full	Full	NNP	B-NP	O
code	code	VBP	B-VP	O
ADDITIONAL	ADDITIONAL	NNP	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
if	if	IN	B-SBAR	O
having	have	VBG	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
with	with	IN	B-PP	O
exertion	exertion	NN	B-NP	O
or	or	CC	B-PP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
,	,	,	O	O
new	new	JJ	B-NP	O
onset	onset	NN	I-NP	O
back/shoulder	back/shoulder	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
fatigue	fatigue	NN	B-NP	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
concerns	concern	NNS	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
call	call	VB	I-VP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
to	to	TO	B-VP	O
schedule	schedule	VB	I-VP	O
out	out	RP	B-PRT	O
patient	patient	NN	B-NP	O
Cardiac	Cardiac	JJ	I-NP	O
MIBI	MIBI	NN	I-NP	O
with	with	IN	B-PP	O
adenosine	adenosine	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
GUENIN	GUENIN	NNP	B-NP	O
,	,	,	O	O
DENVER	DENVER	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
YM63	YM63	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
8/29/04	8/29/04	CD	I-NP	O
@	@	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
37	37	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

